Control group:Placebo, PD1 inhibitor and chemotherapy

2 trials

Sponsors

Shanghai Pulmonary Hospital

Conditions

Non-small Cell Lung Cancer

Early Phase 1

Randomized and placebo-controlled clinical Study of Bushen Tiaoyuan Tongluo Formula in Combination with PD-1 Inhibitor and Chemotherapy for Advanced Non-small Cell Lung Cancer

Active, not recruitingITMCTR2000003240

Shanghai Pulmonary HospitalNon-small Cell Lung Cancer

Start: 2020-06-01Updated: 2023-02-20

Randomized and placebo-controlled clinical Study of Bushen Tiaoyuan Tongluo Formula in Combination with PD-1 Inhibitor and Chemotherapy for Advanced Non-small Cell Lung Cancer

Active, not recruitingChiCTR2000032287

Shanghai Pulmonary HospitalNon-small Cell Lung Cancer

Start: 2020-06-01Updated: 2020-04-27